Aminoácidos (AA)

Applications 1-Boc-3-aminoazetidine (cas# 193269-78-2) is a compound useful in organic synthesis.
References Jenkins, T., et al.: J. Med. Chem., 50, 566 (2007),

Applications 3-Methyl-1-(4-sulfophenyl)-2-pyrazolin-5-one acts as a reagent for the identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors. Ecto-5'-nucleotidase inhibition is thought to provide an attractive approach to cancer therapy.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Iqbal, J., et al.: Eur. J. Med. Chem., 70, 685 (2013)

Applications 4-Chloro-2-fluoro-N-methylbenzamide

Applications Furan-2-ylmethyl-phenethyl-amine is used in the preparation of carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors.
References Papeo, G. M. E., et al.: PCT Int. Appl. 60 pp. (2014)

Applications N,N-Dimethyl-d3-glycine HCl (N-methyl-d3) (CAS# 1219795-14-8) is a useful isotopically labeled research compound.

Stability Hygroscopic
Applications 4-Hydroxy-3-methyoxybenzyl Alcohol is used in the anti-asthmatic activity of phenolic compounds from the roots of Gastrodia elata Bl. Chemical composition, antioxidant and antibacterial activities of lemon peel essential oil.
References Jang, Y. W., et al.: Int. Immunopharmacol., 10, 147 (2010); Zhang, B., et al.: Shipin Gongye Keji, 36, 126 (2015)

Applications 1-(4-Bromo-3-methylphenyl)ethanone

Applications 1-Methylpsilocin is a potent and selective SR-2C agonist.

Applications methyl 2-methyl-3-sulfanylpropanoate (cas# 4131-76-4) is a useful research chemical.

Applications 2,4-Dichloro-5-methylpyrimidine (cas# 1780-31-0) is a compound useful in organic synthesis.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package

Applications N-Methylacetamide-N-d1 (CAS# 3669-70-3) is a useful isotopically labeled research compound.

Applications Fmoc-Dap(Mtt)-OH is used in the synthesis of cyclic peptides as inhibitors targeting substrate recruitment site of cyclin-dependent kinase complexes.
References Andrews, M., et al.: Org. Biomol. Chem., 2, 2735 (2004);